A Novel Metabotropic Glutamate Receptor 5 Positive Allosteric Modulator Acts at a Unique Site and Confers Stimulus Bias to mGlu5 Signaling

Metabotropic glutamate receptor 5 (mGlu(5)) is a target for the treatment of central nervous system (CNS) disorders, such as schizophrenia and Alzheimer’s disease. Furthermore, mGlu(5) has been shown to play an important role in hippocampal synaptic plasticity, specifically in long-term depression (...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Noetzel, M. J., Gregory, K. J., Vinson, P. N., Manka, J. T., Stauffer, S. R., Lindsley, C. W., Niswender, C. M., Xiang, Z., Conn, P. J.
Formato: Artigo
Lenguaje:Inglês
Publicado: The American Society for Pharmacology and Experimental Therapeutics 2013
Materias:
Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3608436/
https://ncbi.nlm.nih.gov/pubmed/23348500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.112.082891
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares